High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
Journal article published in 2012 by
A. Willems Jones,
L. Kavanagh,
D. Clouston,
D. Bolton,
kConFab Investigators,
S. Fox,
H. Thorne 
